Skip to content

Evaluation of clinical efficacy of Jiuox herb heat-sensitive suspension moxibustion in the treatment of allergic rhinitis:A clinical multicenter randomized controlled pre-experiment

Pre-trial study of Jiuox herb heat-sensitive suspension moxibustion in the treatment of allergic rhinitis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067627
Enrollment
Unknown
Registered
2023-01-15
Start date
2023-01-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

Experimental group:Nine-ox herb heat sensitive suspension moxibustion
Control group:Nanyang moxibustion heat-sensitive suspense

Sponsors

Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All six criteria must be met. A.Patients who meet the above diagnostic criteria are mainly patients with mild-moderate (with TNSS score as the main limiting criterion, at least 3 of the 4 symptoms such as sneezing <= 2 points, and the total TNSS score <=8 points). B. Age 18-65 years old, gender is not limited; C. Voluntarily participate in this clinical observation and sign the informed consent form; D. Be able to obey the doctor's treatment arrangements and be able to cooperate with the doctor's treatment and follow-up. E. Patients with clear consciousness, can correctly express moxibustion sense, and can produce moxibustion sensation in the upper Yin Tang acupoint area (Shangyin Tang is the center, 1 inch each on the top, bottom, left and right), behavior cooperation; F. Voluntary test and signed informed consent.

Exclusion criteria

Exclusion criteria: Any of the following circumstances must be excluded. A.Patients with severe cardiovascular and cerebrovascular, liver, kidney, hematopoietic system and other diseases; B.Have other nasal diseases, such as chronic rhinitis, sinusitis, nasal polyps, deviated nasal septum, etc.; C.Psychopaths, pregnant or lactating women; D.Patients with asthma, bronchitis and other upper respiratory diseases; E.Acupuncture, dizziness or rejection of acupuncture; F. Those who are intolerant to moxa.

Design outcomes

Primary

MeasureTime frame
TNSS+TNNSS;RQLQ;

Secondary

MeasureTime frame
Moxibustion scale;Moxibustion sensation excitation rate;

Countries

China

Contacts

Public ContactJunXiong

Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine

xiongjun196071@163.com+86 139 7005 4277

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026